When his dog was diagnosed with cancer, he decided to explore unconventional solutions. He used artificial intelligence to find a potential treatment. The experimental vaccine ended up delivering results that surprised even the scientists.
The story of Rosie the dog shows how far medicine is progressing today. Her owner, Paul Conyngham, adopted her back in 2019. A few years later, she was given a serious diagnosis: an aggressive form of mastocytoma.
They tried the usual treatments. Surgeries and chemotherapy slowed things down but didn’t make the tumor disappear. So, Paul thought about how he could help his dog and looked for new solutions. He eventually decided to take a different approach, using technologies he's familiar with, including artificial intelligence, as reported by Interesting Engineering.
Paul, along with researchers from the University of New South Wales, conducted a genetic analysis of the tumor. This revealed specific mutations responsible for its growth. Using this data, they came up with a tailored treatment plan.
An mRNA vaccine played a key role, designed by the team around expert Pall Thordarson from the UNSW RNA Institute. Based on the gathered data, scientists created an mRNA vaccine specifically tailored to Rosie's condition.
This type of vaccine works by “giving cells instructions” to produce proteins, which the immune system then recognizes and fights against. In this case, the vaccine was precisely customized according to the genetic changes in the dog’s tumor.
The result surprised even the scientists, as the tumor shrank by about half. According to experts, this might be one of the first examples of such personalized treatment in a dog.
